Stay updated on Cabozantinib for PN in NF1: Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib for PN in NF1: Clinical Trial page.

Latest updates to the Cabozantinib for PN in NF1: Clinical Trial page
- Check4 days agoChange DetectedA new revision tag (v3.6.6) appears on the page. This indicates a minor update to the page’s version, while the study details themselves appear unchanged.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedThe page now lists a new revision—v3.6.5—superseding the previous v3.6.4, reflecting a backend or documentation update. No substantive changes to the visible content or layout are indicated by this revision.SummaryDifference0.0%

- Check40 days agoChange DetectedThe page now shows revision v3.6.4 instead of v3.6.3, indicating a minor metadata update to the page.SummaryDifference0.0%

- Check62 days agoChange DetectedThe page revision has been updated from v3.6.2 to v3.6.3, indicating a backend/documentation update. No study details, eligibility criteria, outcomes, or visible content were altered.SummaryDifference0.0%

- Check69 days agoChange DetectedRevision label updated from v3.6.0 to v3.6.2 on the page. This indicates an internal update to the release, with no explicit changes to the displayed study content.SummaryDifference0.0%

- Check83 days agoChange DetectedThe page now marks recruitment as closed. New help sections (How to Read a Study Record, Common Questions, How to Join a Study) appear, the Intervention/Treatment heading is standardized, and the revision tag updates to v3.6.0.SummaryDifference0.4%

Stay in the know with updates to Cabozantinib for PN in NF1: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib for PN in NF1: Clinical Trial page.